Among them, 3 families with HypoPP and 1 family with HyperPP carried mutations in the SCN4A gene (31 patients), while 1 carried a mutation in the CACNA1S gene (7 patients) (Fig. 2). This evidence concerns the gene SCN4A and hyperkalemic periodic paralysis.